NEW
YORK, July 18, 2024 /PRNewswire/ -- The global
amniotic membrane market size is estimated to grow by USD 2.72 billion from 2024-2028, according
to Technavio. The market is estimated to grow at a CAGR of
about 15.19% during the forecast period. Extensive use
of amniotic membrane transplantation in ophthalmic
surgeries is driving market growth, with a trend
towards growing reimbursement coverage for new products.
However, limited supply of amniotic membranes poses a
challenge. Key market players include Amnio Technology LLC, Applied
Biologics LLC, BIOHEALING SRO, Celularity Inc., Flower Orthopedics
Corp., Human Regenerative Technologies LLC, Integra Lifesciences
Corp., Katena Products Inc., Merakris Therapeutics Inc., MiMedx
Group Inc., Next Biosciences Pty Ltd., NuVision Biotherapies Ltd,
Organogenesis Holdings Inc., Orthofix Medical Inc., Reea carewell
products, Skye Biologics Holdings LLC, Stryker Corp., Surgenex LLC,
SURGITECH INNOVATION, and TissueTech Inc..
Get a detailed analysis on regions, market
segments, customer landscape, and companies- View the
snapshot of this report
Amniotic Membrane
Market Scope
|
Report
Coverage
|
Details
|
Base year
|
2023
|
Historic
period
|
2018 - 2022
|
Forecast
period
|
2024-2028
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
15.19%
|
Market growth
2024-2028
|
USD 2724.8
million
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
13.37
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
56%
|
Key
countries
|
US, Canada, Germany,
UK, and France
|
Key companies
profiled
|
Amnio Technology LLC,
Applied Biologics LLC, BIOHEALING SRO, Celularity Inc., Flower
Orthopedics Corp., Human Regenerative Technologies LLC, Integra
Lifesciences Corp., Katena Products Inc., Merakris Therapeutics
Inc., MiMedx Group Inc., Next Biosciences Pty Ltd., NuVision
Biotherapies Ltd, Organogenesis Holdings Inc., Orthofix Medical
Inc., Reea carewell products, Skye Biologics Holdings LLC, Stryker
Corp., Surgenex LLC, SURGITECH INNOVATION, and TissueTech
Inc.
|
Market Driver
Governments worldwide are adjusting reimbursement structures to
cover advanced healthcare products, including amniotic membranes.
These tissue-engineered products come with significant costs due to
sourcing, storage, transfer, and application expenses. For
instance, amniotic membrane applications can cost up to
USD1,000. High costs pose challenges
for market vendors. However, government organizations and vendors
collaborate to provide value-based care and revise reimbursement
policies. The Centers for Medicare & Medicaid Services (CMS)
recently updated HCPCS codes for amniotic membrane-based products,
including new products. Regulatory authorities require reporting of
adverse events or complications related to these products. Market
vendors partner with third-party payers and Medicare administrative
contractors to expand reimbursement coverage, lowering costs and
increasing awareness among patients and medical practitioners.
These efforts are anticipated to fuel the growth of the global
amniotic membrane market.
The Amniotic Membrane market is witnessing significant growth
due to increasing trends in tissue-based products and transplant
procedures. The market includes segments like surgical wounds,
ophthalmology, and ASCs, catering to various surgical
subspecialties. Amniotic membranes, derived from the amnion, offer
advanced technologies for medical treatments in eye conditions such
as corneal ulcers and pterygium excisions. The market is driven by
unmet healthcare needs in areas like ocular diseases, burn
injuries, and non-healing chronic wounds. Amniotic membranes'
anti-inflammatory, anti-scarring, and antibacterial properties make
them ideal for surgical grafts and biological bandages. Donations
from cesarean deliveries provide a rich source for dehydrated
amniotic membranes. The market includes key players providing
amniotic transplants and amniotic membranes for ophthalmology
surgeries, cosmetic surgeries, and orthopedics surgeries.
Healthcare facilities and specialty clinics are major consumers.
Alternative technologies and pressure ulcers are emerging trends.
Regenerative medicine, including limbic stem cells and human cells,
is a promising area. Amniotic membranes' cryopreserved segments
offer long-term storage and accessibility. The market faces
competition from other wound care biologics.
Discover 360° analysis of this market. For
complete information, schedule your consultation - Book
Here!
Market Challenges
- The amniotic membrane market has experienced rising demand due
to its increasing adoption in various medical applications.
However, the limited availability of amniotic membranes poses a
significant challenge for market vendors. These membranes can only
be sourced during childbirth through cesarean sections, making
their supply insufficient to meet the high demand. The scarcity of
supply results in increased prices, contributing to higher
healthcare costs. Moreover, regulatory requirements, such as
obtaining informed consent from donors and serological screening
for communicable diseases, further restrict the availability of
sources. Ethical concerns surrounding placental tissue donation
also reduce the number of donors, creating a considerable gap
between demand and supply. To address the supply shortage,
end-users are exploring alternatives, such as synthetic polymeric
scaffolds. Manufacturers of synthetic biologics are developing
pipeline products, like 3D-printed membranes and electrospinning
technology, to create fully resorbable synthetic membranes with
comparable benefits to naturally derived amniotic membranes. These
factors may hinder the growth of the global amniotic membrane
market during the forecast period.
- The Amniotic Membrane Market is experiencing significant growth
due to the increasing demand for amniotic transplants and medical
treatments using amniotic membranes. Challenges in ocular diseases,
burn injuries, and non-healing chronic wounds have led amniotic
providers to explore the use of these membranes for their
anti-inflammatory, anti-scarring, and antibacterial properties. In
ophthalmology surgeries and cosmetic procedures, amniotic membranes
are used for surgical recovery and eye care. The market also caters
to orthopedics surgeries, drug development technology, and
cryopreserved or frozen amniotic membranes. Amniotic Allografts are
used for surgical wounds, corneal epithelia, and lyophilized
amniotic membranes. The hospitals segment, sports medicine,
podiatry treatment, and tissue transplant are other significant
areas of application. Human cells and regenerative medicines like
Amnioeffect, Placenta, and Avascular stromal cells are also gaining
popularity. Medical advancements and surgical innovations continue
to drive the market, with a focus on burn treatment and tissue
transplant using living tissue donors. Lyophilization Amniotic and
Avascular stromal are also emerging trends.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This amniotic membrane market report extensively covers market
segmentation by
- End-user
- 1.1 Hospitals
- 1.2 Ambulatory surgical centers
- 1.3 Specialty clinics
- 1.4 Research and academic institutes
- Type
- 2.1 Cryopreserved amniotic membrane
- 2.2 Dehydrated amniotic membrane
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Hospitals- The amniotic membrane, sourced from
the innermost placenta layer, is a valuable biological material in
healthcare due to its unique properties. These include
anti-inflammatory and anti-microbial capabilities, making it
suitable for various medical applications. In hospitals, its uses
span across ophthalmology, wound healing, and dermatology. In
ophthalmology, it's utilized as a graft for promoting wound
healing, reducing scarring, and treating ocular surface disorders.
For wound healing, it functions as a biological dressing for
chronic non-healing wounds, providing a moist environment, pain
relief, and speeding up the healing process. In dermatology, it's
used for skin conditions treatment, either topically or as a graft
for wound healing, scar revision, and tissue regeneration. In
gynecology and obstetrics, it holds potential for repairing vaginal
or cervical lacerations, promoting post-surgical healing, and
treating conditions like intrauterine adhesions. The wide
application of amniotic membranes in hospitals will fuel the growth
of the global amniotic membrane market.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2017-2021) - Download a Sample Report
Learn and explore more about Technavio's in-depth research
reports
The global RO membrane market is poised for substantial growth
driven by increasing demand for clean water solutions in industrial
and residential sectors. Key players are focusing on technological
advancements to enhance efficiency and sustainability. With rising
environmental regulations and industrial applications, the global
gas separation membrane market is expanding. Innovations in
membrane materials and processes are crucial for meeting stringent
purity requirements in gas separation processes. The membrane
market in food and beverage processing is thriving due to its role
in improving product quality and extending shelf life. Growing
consumer preference for healthy and minimally processed foods is
driving adoption across the globe.
Research Analysis
The Amniotic Membrane Market refers to the growing demand for
amniotic transplants and amniotic membranes in various medical
treatments. These membranes, derived from human placentas, offer
numerous benefits including anti-inflammatory, anti-scarring, and
antibacterial properties. Amniotic providers are leveraging
advanced technology for drug development and preservation methods
like cryopreservation and freezing to expand their offerings.
Amniotic membranes find extensive applications in ocular diseases,
burn injuries, and non-healing chronic wounds. In ophthalmology,
they are used for eye care, particularly in surgeries for corneal
epithelia and dry eye disease. In wound care, amniotic allografts
are utilized for surgical wounds and blood vessel repair. The
market is witnessing significant medical advancements, with the
introduction of lyophilized amniotic tissue and frozen amniotic
membranes, broadening the scope of their applications.
Market Research Overview
Amniotic membranes, derived from the innermost layer of the
placenta, have emerged as valuable medical treatments for various
conditions. These membranes offer anti-inflammatory, anti-scarring,
and antibacterial properties, making them ideal for use in ocular
diseases, burn injuries, and non-healing chronic wounds. Amniotic
transplants, also known as amniotic membrane grafts or allografts,
have gained popularity in ophthalmology surgeries, cosmetic
surgeries, orthopedics, and sports medicine. The use of human cells
from these membranes in regenerative medicines, such as
Amnioeffect, is a promising area of research. The market for
amniotic membranes is segmented into cryopreserved and frozen
forms, ophthalmology, wound care, and surgical subspecialties.
Medical advancements and surgical innovations continue to expand
the applications of these tissue-based products, including in eye
care, surgical recovery, and advanced technologies like lyophilized
amniotic membranes and avascular stromal cells. Unmet healthcare
needs in areas like pain management, bacterial growth inhibition,
and tissue transplant procedures are driving the growth of this
market. Donations from living tissue donors are essential for the
production of these valuable grafts. The market includes various
segments, such as hospitals, specialty clinics, and healthcare
facilities, and alternative technologies are also emerging to cater
to the evolving needs of healthcare providers.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- End-user
-
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research And Academic Institutes
- Type
-
- Cryopreserved Amniotic Membrane
- Dehydrated Amniotic Membrane
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amniotic-membrane-market-size-is-set-to-grow-by-usd-2-72-billion-from-2024-2028--extensive-use-of-amniotic-membrane-transplantation-in-ophthalmic-surgeries-boost-the-market-technavio-302199124.html
SOURCE Technavio